Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
Hoog-risico gelokaliseerde prostaatkanker: prostatectomie of bestraling?
nov 2022 | Radiotherapie, Uro-oncologie